By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Uppsala, Sweden-based Olink Bioscience has allied with Beijing Pioneer Medical Instrument (PioneerBiomed) to distribute its protein research technology in China.

Under the agreement, PioneerBiomed will distribute Olink Bioscience's Duolink product line to its clients in academic, clinical, and government labs, and to biotechnology and pharmaceutical customers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.